In a study by Wang T. et al. (2021), it was reported that circASK1 (hsa_circ_0007798) was significantly downregulated in gefitinib-resistant cells and enhanced the sensitivity of EGFR-mutant lung adenocarcinoma (LUAD) cells to gefitinib. The gene discussed is EGFR; the disease is lung adenocarcinoma.